Programmed Cell Death Ligand 1 Expression in Resected Lung Adenocarcinomas: Association with Immune Microenvironment
Tiffany G. Huynh(Massachusetts General Hospital), Mari Mino–Kenudson(Brigham and Women's Hospital)
Cited by 88
Related Papers
A Novel, Highly Sensitive Antibody Allows for the Routine Detection of <i>ALK</i> -Rearranged Lung Adenocarcinomas by Standard Immunohistochemistry
|Clinical Cancer Research|2010|423
PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes
|Modern Pathology|2016|306
Programmed cell death ligand-1 (PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
|Cancer Biology and Medicine|2016|97
Immunohistochemistry for predictive biomarkers in non-small cell lung cancer
|Translational Lung Cancer Research|2017|60